Quantification of Proteomes: L-plastin , Lipocalin & Adiponectin in

Status Completed

Clinical Trial Summary

The quantification of the proteomes : L-plastin, lipocalin and adiponectin was analysed in the subgingival tissue samples of generalized severe chronic periodontitis patients with and without diabetes mellitus.The demographic and the periodontal parameters were assessed and the correlated with the quantification of the proteins. The mRNA expression was analyzed with RT-PCR and the quantification of protein was done using ELISA.

Clinical Trial Description

The quantification of the proteomes : L-plastin, lipocalin and adiponectin was analysed in the subgingival tissue samples of generalized severe chronic periodontitis patients with and without diabetes mellitus.A total of 70 subjects with generalized severe chronic periodontitis were selected and divided into two groups. Group I comprised of 35 subjects who were diagnosed with generalized severe chronic periodontitis without any systemic conditions. Group II comprised of generalized severe chronic periodontitis patients with type II diabetes mellitus. Demographic variables such as age, weight, height, BMI and income and the clinical parameters such as plaque index, bleeding on probing, probing pocket depth and clinical attachment level were recorded. Subgingival tissue samples were collected from both the groups from the periodontal surgical site. The collected samples were subjected to further molecular analysis for the mRNA expression of L-plastin, lipocalin and adiponectin using RT-PCR and for their protein quantification using ELISA.The elevated levels of mRNA expression and elevated quantification of L-plastin and Lipocalin proteins in the subgingival tissue samples of generalized severe chronic periodontitis subjects with diabetes denoted the localized involvement of these molecules in the pathogenesis of both periodontitis and type II diabetes mellitus. Since adiponectin was reduced in periodontitis patients with type II diabetes mellitus, it can be used as an anti-inflammatory and anti-diabetic biomarker for the early identification of patients at risk for diabetes mellitus and periodontitis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03391349
Study type	Observational
Source	Meenakshi Ammal Dental College and Hospital
Contact
Status	Completed
Phase	N/A
Start date	October 20, 2016
Completion date	December 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04712630` - Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft	N/A
Recruiting	`NCT03997552` - NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration	N/A
Completed	`NCT04478864` - Knowledge, Practice and State of Periodontal Health
Completed	`NCT03507868` - YKL-40 and IL-6 Levels in Periodontal Disease
Completed	`NCT05720481` - Impact of Periodontal Treatment on Growth Differentiation Factor-15 Levels	N/A
Recruiting	`NCT06052150` - Oral Health In Cirrhosis of the Liver (ORACLE)
Recruiting	`NCT06025955` - Evaluation of Outcomes of Minimally Invasive Non- Surgical Versus Surgical Therapy in Furcation Involvement.	N/A
Recruiting	`NCT03510702` - SCREENING OF EPIGENETIC BIOMARKERS (miRNAs) IN THE GINGIVAL SULCUS
Completed	`NCT05631600` - Manuka Honey as an Adjunct to Non-surgical Periodontal Therapy: Clinical Study	Phase 2/Phase 3
Active, not recruiting	`NCT05068778` - Development of an AI App to Improve Compliance in Periodontal Maintenance Patients
Not yet recruiting	`NCT05178563` - Mechanisms of Acute Inflammation Following Periodontal Treatment	N/A
Recruiting	`NCT06224699` - Toothpaste With Sodium Carbonate in Patients With Gingivitis	N/A
Recruiting	`NCT06086821` - Clinical Relevance of Different Time of Periodontal Re-evaluation	N/A
Not yet recruiting	`NCT05721313` - Vital Root Amputation in Molars With Advanced Periodontal Furcation Involvement: a Preliminary Study	N/A
Completed	`NCT06306937` - Serum Levels of Vitamin D and IL8 in Patients With Periodontitis
Completed	`NCT06040944` - Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
Recruiting	`NCT04669717` - Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies	Phase 4
Completed	`NCT05576142` - Oral Findings in Pediatric Patients With Allergic Rhinitis and/or Asthma
Not yet recruiting	`NCT03588507` - Clinical and Radiographic Evaluation of PPF With or Without NCHA Bone in Treatment of Intrabony Defects	N/A
Completed	`NCT03694496` - The Effectiveness of an Oral Health Education Programme of Adolescents in Hong Kong	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Quantification of Proteomes: L-plastin , Lipocalin and Adiponectin in Chronic Periodontitis and Diabetic Subjects

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms